1 completed, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow CKD-581: new trials by email Literature Review of CKD-581 trials Research Report on CKD-581
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma CKD-581 - Myeloma, Multiple | Phase 1 | Unknown | Chong Kun Dang Pharmaceutical | 18 | 2017-01-01 | 2020-02-24 |
| Safety and Pharmacokinetic Profile of CKD-581 CKD-581 - Lymphoma, Multiple Myeloma | Phase 1 | Completed | Chong Kun Dang Pharmaceutical | 39 | 2012-05-01 | 2016-10-06 |
Multiple Myeloma (2) · Lymphoma (1)
Chong Kun Dang Pharmaceutical (2)
South Korea (2)
Dok Hyun Yoon, Ph.D (1) · Min Ji Song (1)